Hollsteen
← Texas Instruments

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 2016: $322M · 10-Q 0001564590-17-008260 filed May 3, 2017Research and development · Q2 2016: $341M · 10-Q 0001564590-17-015153 filed Aug 3, 2017Research and development · Q3 2016: $353M · 10-Q 0001564590-17-021032 filed Nov 2, 2017Research and development · Q4 2016: $340M · derived · 10-K 0001564590-18-002832 filed Feb 22, 2018Research and development · Q1 2017: $369M · 10-Q 0001564590-17-008260 filed May 3, 2017Research and development · Q2 2017: $378M · 10-Q 0001564590-17-015153 filed Aug 3, 2017Research and development · Q3 2017: $375M · 10-Q 0001564590-17-021032 filed Nov 2, 2017Research and development · Q4 2017: $386M · derived · 10-K 0001564590-19-003839 filed Feb 22, 2019Research and development · Q1 2018: $385M · 10-Q 0001564590-18-010545 filed May 3, 2018Research and development · Q2 2018: $384M · 10-Q 0001564590-18-018753 filed Aug 2, 2018Research and development · Q3 2018: $390M · 10-Q 0001564590-18-026405 filed Nov 2, 2018Research and development · Q4 2018: $400M · derived · 10-K 0000097476-20-000009 filed Feb 20, 2020Research and development · Q1 2019: $389M · 10-Q 0001564590-19-014051 filed Apr 30, 2019Research and development · Q2 2019: $390M · 10-Q 0001564590-19-027328 filed Jul 31, 2019Research and development · Q3 2019: $379M · 10-Q 0000097476-19-000009 filed Oct 31, 2019Research and development · Q4 2019: $386M · derived · 10-K 0000097476-21-000006 filed Feb 5, 2021Research and development · Q1 2020: $377M · 10-Q 0000097476-20-000017 filed Apr 22, 2020Research and development · Q2 2020: $379M · 10-Q 0000097476-20-000026 filed Jul 22, 2020Research and development · Q3 2020: $386M · 10-Q 0001628280-20-014630 filed Oct 21, 2020Research and development · Q4 2020: $388M · derived · 10-K 0000097476-22-000009 filed Feb 4, 2022Research and development · Q1 2021: $386M · 10-Q 0000097476-21-000013 filed Apr 28, 2021Research and development · Q2 2021: $391M · 10-Q 0000097476-21-000020 filed Jul 22, 2021Research and development · Q3 2021: $388M · 10-Q 0000097476-21-000032 filed Oct 27, 2021Research and development · Q4 2021: $389M · derived · 10-K 0000097476-23-000007 filed Feb 3, 2023Research and development · Q1 2022: $391M · 10-Q 0000097476-22-000028 filed Apr 27, 2022Research and development · Q2 2022: $414M · 10-Q 0000097476-22-000040 filed Jul 27, 2022Research and development · Q3 2022: $431M · 10-Q 0000097476-22-000048 filed Oct 26, 2022Research and development · Q4 2022: $434M · derived · 10-K 0000097476-24-000007 filed Feb 2, 2024Research and development · Q1 2023: $455M · 10-Q 0000097476-23-000025 filed Apr 26, 2023Research and development · Q2 2023: $477M · 10-Q 0000097476-23-000035 filed Jul 26, 2023Research and development · Q3 2023: $471M · 10-Q 0000097476-23-000041 filed Oct 25, 2023Research and development · Q4 2023: $460M · derived · 10-K 0000097476-25-000007 filed Feb 14, 2025Research and development · Q1 2024: $478M · 10-Q 0000097476-24-000021 filed Apr 24, 2024Research and development · Q2 2024: $498M · 10-Q 0000097476-24-000030 filed Jul 24, 2024Research and development · Q3 2024: $492M · 10-Q 0000097476-24-000042 filed Oct 23, 2024Research and development · Q4 2024: $491M · derived · 10-K 0000097476-26-000059 filed Feb 6, 2026Research and development · Q1 2025: $517M · 10-Q 0000097476-25-000027 filed Apr 24, 2025Research and development · Q2 2025: $527M · 10-Q 0000097476-25-000036 filed Jul 29, 2025Research and development · Q3 2025: $518M · 10-Q 0000097476-25-000060 filed Oct 23, 2025Research and development · Q4 2025: $521M · derived · 10-K 0000097476-26-000059 filed Feb 6, 2026Research and development · Q1 2026: $510M · 10-Q 0000097476-26-000101 filed Apr 24, 2026Research and development · Q2 2026: $535M · 10-Q 0000097476-26-000152 filed Jul 24, 2026414535322Q1 2016Q2 2026Q2 2022
Q2 2022
414$M
All values (42)
PeriodValue ($M)Status
Q2 2026535reported
Q1 2026510reported
Q4 2025521derived
Q3 2025518reported
Q2 2025527reported
Q1 2025517reported
Q4 2024491derived
Q3 2024492reported
Q2 2024498reported
Q1 2024478reported
Q4 2023460derived
Q3 2023471reported
Q2 2023477reported
Q1 2023455reported
Q4 2022434derived
Q3 2022431reported
Q2 2022414reported
Q1 2022391reported
Q4 2021389derived
Q3 2021388reported
Q2 2021391reported
Q1 2021386reported
Q4 2020388derived
Q3 2020386reported
Q2 2020379reported
Q1 2020377reported
Q4 2019386derived
Q3 2019379reported
Q2 2019390reported
Q1 2019389reported
Q4 2018400derived
Q3 2018390reported
Q2 2018384reported
Q1 2018385reported
Q4 2017386derived
Q3 2017375reported
Q2 2017378reported
Q1 2017369reported
Q4 2016340derived
Q3 2016353reported
Q2 2016341reported
Q1 2016322reported

CSV with all sources · Technical ID: rnd

More metrics for Texas Instruments
Sources & calculation
Value
$414M
Period
Q2 2022, ended Jun 30, 2022 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Jul 27, 2022 · 0000097476-22-000040
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$414MJul 27, 202210-Q 0000097476-22-000040reported · confidence 1. · current